
This episode discusses the significant stock movements of Eli Lilly, Caterpillar, and Royal Caribbean based on their recent earnings and forecasts.
On this episode of Stock Movers: - Eli Lilly (LLY) surprised Wall Street by raising its annual sales and profit forecast, as demand for obesity medications soared and thousands of patients started taking its new weight-loss pill before advertising for the drug had even begun. Lilly shares jumped 7.3% at the start of regular trading in New York, its largest gain since February and continued to rally during the day. - Caterpillar (CAT)'s shares surged after the company delivered stronger-than-expected quarterly earnings and raised its long-term revenue outlook, supported by fast-growing sales from construction and power generation equipment. Shares rose about 9% in morning trading on Thursday in New York after the US manufacturer said it now expects sales through the end of the decade to grow at a faster clip than it had previously forecast and continued in the green throughout trading. - Royal Caribbean (RCL) shares rose as the company’s outlook for the year suggests it will be able to weather headwinds such as higher fuel costs and disruptions on its Middle Eastern itineraries. The cruise operator cut its full-year adjusted earnings forecast to $17.10 to $17.50 a share…
Organizations: Eli Lilly, Caterpillar, Royal Caribbean
Products: weight-loss pill
Places: New York
Explore listener stats, chart rankings, contacts and more on the Stock Movers podcast page.